We have updated our Online Services Terms of Use and Privacy Policy. See our Cookies Notice for information concerning our use of cookies and similar technologies. By using this website or clicking “I ACCEPT”, you consent to our Online Services Terms of Use.


Sickle Cell Disease and CardiovAscular Risk - Red cell Exchange Trial (SCD-CARRE)

red blood cells


AGE: 18+ years old
TYPE: Interventional Study
CONDITION: Sickle Cell Disease (SCD)
LOCATION: UH Cleveland Medical Center

Learn More About This Research Study

To learn more about this study, please call study coordinator, Anne Windau at 216-286-7562 or complete the online form below.

Study Purpose

The purpose of this study is to see the effects of giving long-term red blood cell exchange transfusion to patients with sickle cell disease (SCD). We want to know if exchange blood transfusion may help with complications of SCD or reduce the chances of new serious problems happening.

Who Can Participate

Participants 18 years old and older with a diagnosis of sickle cell disease may be eligible for this study.

Request More Information

To learn more about this study, please fill out the form below to request more information.

I'm not a robot

Study ID: